Stay updated on Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This indicates a minor update or patch to the page’s documentation or underlying components.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5, signaling a backend/template update. No study information or user-facing content appears to be affected.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4; this reflects a new release label rather than any change to the study details.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a minor update to the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check76 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2, representing a minor administrative update to the page documentation.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page now indicates recruitment is closed and introduces new guidance sections for reading the study record and joining the study, along with a formatting change to the Intervention/Treatment heading and a revision note (Revision: v3.6.0).SummaryDifference0.4%

Stay in the know with updates to Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Metastatic Uveal Melanoma Clinical Trial page.